May 12th, 2020: Hikma Pharmaceuticals PLC, the multinational pharmaceutical company announced the launch of propofol injectable emulsion, USP, 20ml, 50ml as well as 100 ml vials, in the United States of America through its US affiliate, Hikma Pharmaceuticals USA Inc., by the approval of its supplemental Abbreviated New Drug Application by the U.S. Food and Drug Administration (FDA).
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?